Evaluated by: David B. Kaminsky, M.D., FIAC, August 15, 2017
Original release date: August 15, 2017
Access to this course expires on: January 14, 2020
Faculty: Martha Bishop Pitman, M.D.
- Recognize benign hepatocytes and bile duct epithelium
- Know the criteria for well-differentiated hepatocellular carcinoma
- Understand the ancillary tests useful in the differential diagnosis of benign and malignant hepatocellular lesions
- Understand the ancillary tests helpful in the distinction between primary and metastatic malignancies that mimic hepatocellular carcinoma
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
$75.00 - $100.00